miR-654-5p promotes gastric cancer progression via the GPRIN1/NF-κB pathway

Zhou Weidong; Li Peifei; Jin Peihua

doi:10.1515/med-2021-0369

Open Medicine (Nov 2021)

miR-654-5p promotes gastric cancer progression via the GPRIN1/NF-κB pathway

Zhou Weidong,
Li Peifei,
Jin Peihua

Affiliations

Zhou Weidong: Department of Gastroenterology, Hwa Mei Hospital, University of Chinese Academy of Sciences (Ningbo No. 2 Hospital), 41Xibei Street, Ningbo 315010, Zhejiang, China
Li Peifei: Department of Gastroenterology, Ningbo First Hospital, Ningbo 315010, Zhejiang, China
Jin Peihua: Department of Gastroenterology, Hwa Mei Hospital, University of Chinese Academy of Sciences (Ningbo No. 2 Hospital), Ningbo 315010, Zhejiang, China

DOI: https://doi.org/10.1515/med-2021-0369
Journal volume & issue: Vol. 16, no. 1
pp. 1683 – 1695

Abstract

Read online

Gastric carcinoma (GC) ranks the fifth most common cancer worldwide, with high incidence and mortality rates. Numerous microRNAs (miRNAs), including miR-654-5p, have been implicated in the pathophysiological processes of tumorigenesis. Nevertheless, the mechanism of miR-654-5p in GC is unclear.

Published in Open Medicine

ISSN: 2391-5463 (Online)
Publisher: De Gruyter
Country of publisher: Poland
LCC subjects: Medicine
Website: https://www.degruyter.com/journal/key/med/html

About the journal

Abstract

Keywords